Company news
Hanmi Pharmaceutical Co., Ltd. news in 2026
Hanmi Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.
MegazoneCloud Begins Building Hanmi Pharmaceutical's Quality Assurance AI Agent with 'AIR Studio'
September 8, 2026
Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights
March 31, 2026
Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical
March 19, 2026
Rolvedon (Hanmi Pharm) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
March 13, 2026
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
February 24, 2026
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More
January 27, 2026